Skip to main content
. 2019 Jan;17(1):33–58. doi: 10.2174/1570159X16666180917105033

Table 2.

Clinical profiles of gluten ataxia and anti-GAD65 Ab-associated cerebellar ataxia.

Gluten Ataxia Anti-GAD65 Ab-associated Cerebellar Ataxia
Clinical profile
Time course Insidious and chronic Insidious and chronic or subacute
Age and sex 50s, female (55%) 60s, female (mostly)
Main symptoms of cerebellar
involvement
Gait ataxia. Limb ataxia and nystagmus are mild and less frequent (60-70%) Gait ataxia. Limb ataxia and nystagmus are mild and less frequent (60-70%)
Associated neurological symptoms Cortical myoclonus, neuropathy Stiff person syndrome, epilepsy
Abnormality in cerebrospinal fluid Generally none Sometimes; CSF oligoclonal bands
Cerebellar atrophy on MRI Present depending on duration of ataxia. The vermis is primarily involved. The degree of atrophy is mild
relative to ataxia
Present depending on duration of ataxia
The vermis is primarily involved. The degree of
atrophy is mild relative to ataxia
Clues for diagnosis
Neurological features suggestive the need for further investigations on autoimmunity:
  • 40-60s, female
  • Gait ataxia with dominant vermian atrophy
  • Atrophy on MRI is milder relative to the severity of ataxia
Gluten Ataxia Anti-GAD65Ab-associated Cerebellar Ataxia
Autoimmune background
Trigger of autoimmunity Gluten ingestion Unknown
HLA Type DQ2 or DQ8 -
Well characterized autoantibodies Anti-gliadin (IgG/IgA)
Anti-TG2, TG6
Anti-GAD65Ab (high titer) usually exceeds the levels seen in type 1 diabetes mellitus by 100-fold
Associated autoimmune diseases Coeliac disease (47%) Type 1 diabetes mellitus, autoimmune thyroid diseases, pernicious anemia